» Articles » PMID: 32082479

Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers

Overview
Publisher Wiley
Date 2020 Feb 22
PMID 32082479
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Kidney disease represents a serious global health problem. One of the main concerns is its late diagnosis, only feasible in a progressed disease state. The lack of a clinical manifestation in the early stages and the fact that the commonly measured parameters of renal function are markedly reduced only during advanced stages of the disease are the main cause. Changes at the molecular level of the kidney tissue occur even before nitrogenous substances, such as creatinine and urea, start to accumulate in the blood. Renal proximal tubules contain a large number of mitochondria and are critical for the energy-demanding process of reabsorption of water and solutes. Mitochondria are the largest producers of oxygen radicals, which, in turn, increase the susceptibility of kidneys to oxidative stress-induced damage. Free radicals and prooxidants produced during acute or chronic kidney injury may further aggravate the course of the disease and play a role in the pathogenesis of subsequent complications. Prevention might be the solution in CKD, but patients are often reluctant to undergo preventive examinations. Noninvasive markers and the possibility to obtain samples at home might help to increase compliance. This review will provide an overview of the possible uses of markers of oxidative status in noninvasive biofluids in patients with renal disease.

Citing Articles

The exploration of therapeutic potential of bioflavonoids in metabolic acidosis and inflammation-associated with acute kidney injury: Therapeutic potential of bioflavonoids in acute kidney injury.

Al-Bazi M, Banjabi A, Khalifa F, Osrah B, Albishi H, Sabban A Int J Health Sci (Qassim). 2025; 19(2):57-65.

PMID: 40046793 PMC: 11877053.


Naringin vs. L. Peel Extract: An Journey into Oxidative Stress Modulation.

Stabrauskiene J, Sadauskiene I, Liekis A, Mikniene Z, Bernatoniene J Antioxidants (Basel). 2025; 14(2).

PMID: 40002344 PMC: 11852006. DOI: 10.3390/antiox14020157.


Total and Reduced Aminothiols in Blood Plasma as Biochemical Markers of the Effectiveness of Hemodialysis Therapy in Patients with End-Stage Renal Disease.

Dzugkoev S, Dzugkoeva F, Gadieva V Bull Exp Biol Med. 2025; 178(3):315-318.

PMID: 39969685 DOI: 10.1007/s10517-025-06328-8.


Modulation of the thiol redox proteome by sugarcane ash-derived silica nanoparticles: insights into chronic kidney disease of unknown etiology.

Stem A, Michel C, Harris P, Rogers K, Gibb M, Roncal-Jimenez C Part Fibre Toxicol. 2025; 22(1):3.

PMID: 39910563 PMC: 11800628. DOI: 10.1186/s12989-025-00619-8.


Comprehensive Review of Lipid Management in Chronic Kidney Disease and Hemodialysis Patients: Conventional Approaches, and Challenges for Cardiovascular Risk Reduction.

Abidor E, Achkar M, Al Saidi I, Lather T, Jdaidani J, Agarwal A J Clin Med. 2025; 14(2).

PMID: 39860649 PMC: 11765848. DOI: 10.3390/jcm14020643.


References
1.
Jackson P, Loughrey C, Lightbody J, McNamee P, Young I . Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem. 1995; 41(8 Pt 1):1135-8. View

2.
Munch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A . Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem. 1997; 35(9):669-77. DOI: 10.1515/cclm.1997.35.9.669. View

3.
Ustundag S, Sen S, Yalcin O, Ciftci S, Demirkan B, Ture M . L-Carnitine ameliorates glycerol-induced myoglobinuric acute renal failure in rats. Ren Fail. 2009; 31(2):124-33. DOI: 10.1080/08860220802599130. View

4.
Ishimoto Y, Tanaka T, Yoshida Y, Inagi R . Physiological and pathophysiological role of reactive oxygen species and reactive nitrogen species in the kidney. Clin Exp Pharmacol Physiol. 2018; 45(11):1097-1105. PMC: 6221034. DOI: 10.1111/1440-1681.13018. View

5.
Broedbaek K, Siersma V, Henriksen T, Weimann A, Petersen M, Andersen J . Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes. Redox Biol. 2014; 4:34-9. PMC: 4309851. DOI: 10.1016/j.redox.2014.11.010. View